179 related articles for article (PubMed ID: 33742140)
1. Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers.
Aimi F; Moch H; Schraml P; Hottiger MO
Mod Pathol; 2021 Aug; 34(8):1468-1477. PubMed ID: 33742140
[TBL] [Abstract][Full Text] [Related]
2. Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.
Schraml P; Aimi F; Zoche M; Aguilera-Garcia D; Arnold F; Moch H; Hottiger MO
J Pathol Clin Res; 2023 Jul; 9(4):273-284. PubMed ID: 36999983
[TBL] [Abstract][Full Text] [Related]
3. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
4. Serine is the major residue for ADP-ribosylation upon DNA damage.
Palazzo L; Leidecker O; Prokhorova E; Dauben H; Matic I; Ahel I
Elife; 2018 Feb; 7():. PubMed ID: 29480802
[TBL] [Abstract][Full Text] [Related]
5. Systems-wide Analysis of Serine ADP-Ribosylation Reveals Widespread Occurrence and Site-Specific Overlap with Phosphorylation.
Larsen SC; Hendriks IA; Lyon D; Jensen LJ; Nielsen ML
Cell Rep; 2018 Aug; 24(9):2493-2505.e4. PubMed ID: 30157440
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast Cancer.
Krishnan A; Spegg V; Dettwiler S; Schraml P; Moch H; Dedes K; Varga Z; Altmeyer M
Mod Pathol; 2023 Jul; 36(7):100167. PubMed ID: 36990278
[TBL] [Abstract][Full Text] [Related]
7. An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation.
Bonfiglio JJ; Leidecker O; Dauben H; Longarini EJ; Colby T; San Segundo-Acosta P; Perez KA; Matic I
Cell; 2020 Nov; 183(4):1086-1102.e23. PubMed ID: 33186521
[TBL] [Abstract][Full Text] [Related]
8. The fast-growing business of Serine ADP-ribosylation.
Longarini EJ; Matic I
DNA Repair (Amst); 2022 Oct; 118():103382. PubMed ID: 35963141
[TBL] [Abstract][Full Text] [Related]
9. Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.
Buch-Larsen SC; Hendriks IA; Lodge JM; Rykær M; Furtwängler B; Shishkova E; Westphall MS; Coon JJ; Nielsen ML
Cell Rep; 2020 Sep; 32(12):108176. PubMed ID: 32966781
[TBL] [Abstract][Full Text] [Related]
10. Serine ADP-ribosylation marks nucleosomes for ALC1-dependent chromatin remodeling.
Mohapatra J; Tashiro K; Beckner RL; Sierra J; Kilgore JA; Williams NS; Liszczak G
Elife; 2021 Dec; 10():. PubMed ID: 34874266
[TBL] [Abstract][Full Text] [Related]
11. ADP-ribosylation signalling and human disease.
Palazzo L; Mikolčević P; Mikoč A; Ahel I
Open Biol; 2019 Apr; 9(4):190041. PubMed ID: 30991935
[TBL] [Abstract][Full Text] [Related]
12. Protein and RNA ADP-ribosylation detection is influenced by sample preparation and reagents used.
Weixler L; Ikenga NJ; Voorneveld J; Aydin G; Bolte TM; Momoh J; Bütepage M; Golzmann A; Lüscher B; Filippov DV; Žaja R; Feijs KL
Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36368907
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive ADP-ribosylome analysis identifies tyrosine as an ADP-ribose acceptor site.
Leslie Pedrioli DM; Leutert M; Bilan V; Nowak K; Gunasekera K; Ferrari E; Imhof R; Malmström L; Hottiger MO
EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29954836
[TBL] [Abstract][Full Text] [Related]
14. Immunoprecipitation Using Mono-ADP-Ribosylation-Specific Antibodies.
Dauben H; Matic I
Methods Mol Biol; 2023; 2609():135-146. PubMed ID: 36515834
[TBL] [Abstract][Full Text] [Related]
15. PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis.
Kim DS; Challa S; Jones A; Kraus WL
Genes Dev; 2020 Mar; 34(5-6):302-320. PubMed ID: 32029452
[TBL] [Abstract][Full Text] [Related]
16. Interplay of Histone Marks with Serine ADP-Ribosylation.
Bartlett E; Bonfiglio JJ; Prokhorova E; Colby T; Zobel F; Ahel I; Matic I
Cell Rep; 2018 Sep; 24(13):3488-3502.e5. PubMed ID: 30257210
[TBL] [Abstract][Full Text] [Related]
17. ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian Cancers.
Conrad LB; Lin KY; Nandu T; Gibson BA; Lea JS; Kraus WL
Mol Cancer Ther; 2020 Jan; 19(1):282-291. PubMed ID: 31594824
[TBL] [Abstract][Full Text] [Related]
18. Targeting ADP-ribosylation as an antimicrobial strategy.
Catara G; Corteggio A; Valente C; Grimaldi G; Palazzo L
Biochem Pharmacol; 2019 Sep; 167():13-26. PubMed ID: 31176616
[TBL] [Abstract][Full Text] [Related]
19. Chemical ADP-ribosylation: mono-ADPr-peptides and oligo-ADP-ribose.
Liu Q; van der Marel GA; Filippov DV
Org Biomol Chem; 2019 Jun; 17(22):5460-5474. PubMed ID: 31112180
[TBL] [Abstract][Full Text] [Related]
20. A Combined Gas-Phase Separation Strategy for ADP-ribosylated Peptides.
Kasai T; Kuraoka S; Higashi H; Delanghe B; Aikawa M; Singh SA
J Am Soc Mass Spectrom; 2023 Oct; 34(10):2136-2145. PubMed ID: 37589412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
